Divisione Biotecnologie e Agroindustria

Found 13 results

Filtri: Autore is Raschellà, G. [Clear All Filters]

2014

Proteome changes induced by c-myb silencing in human chronic myeloid leukemia cells suggest molecular mechanisms and putative biomarkers of hematopoietic malignancies, Di Carli, M., Tanno Barbara, Capodicasa Cristina, Villani Maria Elena, Salzano A.M., Scaloni A., Raschellà G., Benvenuto Eugenio, and Donini Marcello , Journal of Proteomics, Volume 96, p.200-222, (2014)

2012

Expression of p89 c-Mybex9b, an alternatively spliced form of c-Myb, is required for proliferation and survival of p210BCR/ABL-expressing cells, Manzotti, G., Mariani S.A., Corradini F., Bussolari R., Cesi Vincenzo, Vergalli J., Ferrari-Amorotti G., Fragliasso V., Soliera A.R., Cattelani S., et al. , Blood Cancer Journal, Volume 2, Number 5, (2012)

2011

TGFβ-induced c-Myb affects the expression of EMT-associated genes and promotes invasion of ER+ breast cancer cells, Cesi, Vincenzo, Casciati A., Sesti F., Tanno Barbara, Calabretta B., and Raschellà G. , Cell Cycle, Volume 10, Number 23, p.4149-4161, (2011)

2010

Expression of slug is regulated by c-Myb and is required for invasion and bone marrow homing of cancer cells of different origin, Tanno, Barbara, Sesti F., Cesi Vincenzo, Bossi G., Ferrari-Amorotti G., Bussolari R., Tirindelli D., Calabretta B., and Raschellà G. , Journal of Biological Chemistry, Volume 285, Number 38, p.29434-29445, (2010)

2008

Clinical significance of CXC chemokine receptor-4 and c-Met in childhood rhabdomyosarcoma, Diomedi-Camassei, F., McDowell H.P., De loris M.A., Uccini S., Altavista P., Raschellà G., Vitali Roberta, Mannarino O., De Sio L., Cozzi D.A., et al. , Clinical Cancer Research, Volume 14, Number 13, p.4119-4127, (2008)

Slug (SNAI2) down-regulation by interference facilitates apoptosis and inhibits invasive growth in neuroblastoma preclinical models, Vitali, Roberta, Mancini C., Cesi Vincenzo, Tanno Barbara, Mancuso Mariateresa, Bossi G., Zhang Y., Martinez R.V., Calabretta B., Dominici C., et al. , Clinical Cancer Research, Volume 14, Number 14, p.4622-4630, (2008)

2006

Down-regulation of insulin-like growth factor I receptor activity by NVP-AEW541 has an antitumor effect on neuroblastoma cells in vitro and in vivo, Tanno, Barbara, Mancini C., Vitali Roberta, Mancuso Mariateresa, McDowell H.P., Dominici C., and Raschellà G. , Clinical Cancer Research, Volume 12, Number 22, p.6772-6780, (2006)

2005

Clinical and molecular evidence for c-kit receptor as a therapeutic target in neuroblastic tumors, Uccini, S., Mannarino O., McDowell H.P., Pauser U., Vitali Roberta, Natali P.G., Altavista P., Andreano T., Coco S., Boldrini R., et al. , Clinical Cancer Research, Volume 11, Number 1, p.380-389, (2005)

Silencing of endogenous IGFBP-5 by micro RNA interference affects proliferation, apoptosis and differentiation of neuroblastoma cells, Tanno, Barbara, Cesi Vincenzo, Vitali Roberta, Sesti F., Giuffrida M.L., Mancini C., Calabretta B., and Raschellà G. , Cell Death and Differentiation, Volume 12, Number 3, p.213-223, (2005)

2004

Insulin-like growth factor binding protein 5: Contribution to growth and differentiation of neuroblastoma cells, Cesi, Vincenzo, Vitali Roberta, Tanno Barbara, Giuffrida M.L., Sesti F., Mancini C., and Raschellà G. , Annals of the New York Academy of Sciences, Volume 1028, p.59-68, (2004)

2003

c-Kit is preferentially expressed in MYCN-amplified neuroblastoma and its effect on cell proliferation is inhibited in vitro by STI-571, Vitali, Roberta, Cesi Vincenzo, Nicotra M.R., McDowell H.P., Donfrancesco A., Mannarino O., Natali P.G., Raschellà G., and Dominici C. , International Journal of Cancer, Volume 106, Number 2, p.147-152, (2003)

2000

Neuroblastoma specific effects of DR-nm23 and its mutant forms on differentiation and apoptosis, Negroni, Anna, Venturelli D., Tanno Barbara, Amendola R., Ransac S., Cesi Vincenzo, Calabretta B., and Raschellà G. , Cell Death and Differentiation, Volume 7, Number 9, p.843-850, (2000)

1999

Expression of B-myb in neuroblastoma tumors is a poor prognostic factor independent from MYCN amplification, Raschellà, G., Cesi Vincenzo, Amendola R., Negroni Anna, Tanno Barbara, Altavista P., Tonini G.P., De Bernardi B., and Calabretta B. , Cancer Research, Volume 59, Number 14, p.3365-3368, (1999)